QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Surface OncologyFusion PharmaceuticalsHarpoon TherapeuticsCEL-SCIAVROBIO
SymbolNASDAQ:SURFNASDAQ:FUSNNASDAQ:HARPNYSEAMERICAN:CVMNASDAQ:AVRO
Price Information
Current Price$8.44$12.00$18.31$18.36$11.00
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.31.51.51.41.7
Analysis Score3.33.53.53.53.4
Community Score2.63.12.31.82.7
Dividend Score0.00.00.00.00.0
Ownership Score0.80.81.70.81.7
Earnings & Valuation Score0.00.00.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$12.00$24.33$31.50$23.00$30.60
% Upside from Price Target42.18% upside102.78% upside72.04% upside25.27% upside178.18% upside
Trade Information
Market Cap$343.31 million$500.71 million$464.71 million$744.11 million$400.96 million
Beta2.09N/A0.872.091.41
Average Volume1,286,65657,180324,9061,425,095630,459
Sales & Book Value
Annual Revenue$15.36 millionN/A$5.78 million$560,000.00N/A
Price / Sales22.35N/A80.401,328.77N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.03 per shareN/A$3.82 per share$0.51 per share$5.87 per share
Price / Book4.16N/A4.7936.00N/A
Profitability
Net Income$-54,790,000.00$-16,190,000.00$-55,570,000.00$-30,250,000.00$-72,960,000.00
EPS($1.97)N/A($2.55)($0.74)($2.66)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/A5.83N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-434.74%-5,406.61%N/A
Return on Equity (ROE)-29.77%-26.14%-68.32%-170.96%-51.33%
Return on Assets (ROA)-17.05%-18.26%-29.45%-71.38%-47.65%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.17%N/AN/A0.60%N/A
Current Ratio7.94%55.92%3.49%4.15%9.14%
Quick Ratio7.94%55.92%3.49%3.96%9.14%
Ownership Information
Institutional Ownership Percentage51.97%61.35%79.03%30.03%86.71%
Insider Ownership Percentage35.00%N/A34.90%12.60%4.78%
Miscellaneous
Employees493777N/A123
Shares Outstanding40.68 million41.73 million25.38 million40.53 million36.45 million
Next Earnings Date3/9/2021 (Estimated)3/2/2021 (Estimated)3/11/2021 (Estimated)5/10/2021 (Estimated)3/15/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.